Figure S1 Flowchart of the cohort process.
AP: acute pancreatitis; MAP: mild acute pancreatitis; MSAP: moderately severe acute pancreatitis; SAP: severe acute pancreatitis;
Pancreatic necrosis (n=472)
Treatment choices
Infected pancreatic necrosis (n=164) Sterile pancreatic necrosis (n=87)
Carbapenem resistant Enterobacteriaceae infected pancreatic necrosis (n=75)
Risk analysis Antimicrobial Susceptibility
Clinical outcome after 90 days of
intervention
Alive (n=37) Death (n=38)
Klebsiella pneumoniae
(n=84)
Microbial culture
Category AP (n=3960)
MAP (n=2693) MSAP (n=1069) SAP (n=198)
Conservative treatment (n=221) Therapeutic intervention (n=251)
Exclusion criteria:
(a) Age <18 or >80 years old;
(b) Incomplete medical records;
(c) Duplicated patients;
(d) Loss to follow-up Inclusion criteria:
(a) Clinical manifestations of carbapenem resistant Enterobacteriaceaeinfected
pancreatic necrosis;
(b) Hospitalization and complete clinical data
Escherichia coli (n=21)
Klebsiella ozaenae
(n=17)
Enterobacter cloacae
(n=5)
Proteus mirabilis
(n=4)
Proteus mirabilis
(n=4)
Enterobacter aerogenes
(n=2)
Klebsiella oxytoca
(n=2)